Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 5
1991 2
1994 3
1995 3
1996 2
1997 4
1998 2
1999 5
2000 2
2001 4
2002 4
2003 5
2004 2
2005 13
2006 7
2007 6
2008 3
2009 5
2010 2
2011 1
2013 8
2014 5
2015 5
2016 2
2017 2
2018 3
2019 6
2020 4
2021 3
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. Normanno N, et al. Among authors: caponigro f. Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
Management of recurrent nasopharyngeal carcinoma: current perspectives.
Perri F, Della Vittoria Scarpati G, Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M, Pisconti S, Solla R. Perri F, et al. Among authors: caponigro f. Onco Targets Ther. 2019 Feb 26;12:1583-1591. doi: 10.2147/OTT.S188148. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881013 Free PMC article. Review.
Targeted therapy: a new hope for thyroid carcinomas.
Perri F, Pezzullo L, Chiofalo MG, Lastoria S, Di Gennaro F, Scarpati GD, Caponigro F. Perri F, et al. Among authors: caponigro f. Crit Rev Oncol Hematol. 2015 Apr;94(1):55-63. doi: 10.1016/j.critrevonc.2014.10.012. Epub 2014 Nov 1. Crit Rev Oncol Hematol. 2015. PMID: 25465739 Review.
Therapy of metastatic bladder carcinoma.
Iaffaioli RV, Milano A, Caponigro F. Iaffaioli RV, et al. Among authors: caponigro f. Ann Oncol. 2007 Jun;18 Suppl 6:vi153-6. doi: 10.1093/annonc/mdm246. Ann Oncol. 2007. PMID: 17591811 Free article. Review.
Farnesyl transferase inhibitors in clinical development.
Caponigro F, Casale M, Bryce J. Caponigro F, et al. Expert Opin Investig Drugs. 2003 Jun;12(6):943-54. doi: 10.1517/13543784.12.6.943. Expert Opin Investig Drugs. 2003. PMID: 12783599 Review.
113 results